Solvay Pharmaceuticals, Inc. and its wholly owned subsidiary Unimed Pharmaceuticals, Inc., are part of Solvay S.A., a Belgium-based chemical and pharmaceutical company. Solvay S.A. shares are quoted on EURONEXT BRUSSELS stock exchange and are present in the Euronext 100 index. They are listed in The Wall Street Journal under Foreign Markets - Euronext Brussels - Solvay. Shares may be purchased in the United States via an American Depositary Receipt (ADR) traded over-the-counter and sponsored. These ADRs are managed by the Morgan Guaranty Trust in New York (No. 834437-10-5, ticker SVYSY). One ADR represents exactly one ordinary Solvay S.A. share. On December 31, 2002, the number of ADRs held was about 320,000 shares. The total number of Solvay S.A. shares is 84,600,633. These shares are either to bearer (in denominations of 1, 10, 100 or 1,000 shares), or registered. For more information regarding Solvay S.A. shares, click here or contact the ADRs hotline : 800-997-8970 (from the United States and Canada) and 781-575-4328 (from other countries). You may view the Solvay S.A. 2006 Annual Report online or request a hard copy by contacting: Jessica Mumaw Tel: 770-578-5637 Jessica.mumaw@solvay.com